HOME >> MEDICINE >> NEWS
Reduced risk for developing type 2 diabetes recommended for inclusion in Xenical's European label

Roche announced today that the European Union's Committee for Proprietary Medicinal Products (CPMP) has given a positive recommendation to extend the European label for its weight loss medication Xenical to include:

  • four year data on weight loss;
  • long-term safety and tolerability profile; and
  • reduced risk for developing type 2 diabetes.

    The decision is based on the results of the landmark XENDOS (XENical in the prevention of Diabetes in Obese Subjects) study, which showed for the first time that a weight loss medication could significantly reduce the risk of developing type 2 diabetes.

    XENDOS is the largest and longest study of a weight loss medication, treating 3304 patients for four years with Xenical plus lifestyle changes, or lifestyle changes alone. It is also the first study to assess whether treatment with a weight loss medication, Xenical, can reduce the risk of developing type 2 diabetes. The study showed that losing weight with Xenical reduced the risk of developing diabetes by 37% compared with lifestyle changes alone and by 52% in patients with impaired glucose tolerance (IGT or pre-diabetes). Compared to lifestyle changes alone, Xenical treatment produced significantly greater long-term weight loss and improvements in cardiovascular risk factors (including blood pressure and lipids). The study also confirmed that Xenical has a long-term safety profile that is unmatched in the field of weight loss.

    "The CPMP's decision is an important step towards expanding the European label for Xenical, which we believe will provide physicians with an effective strategy for helping patients lose weight and thereby delaying or preventing type 2 diabetes," commented Dr. Paul Brown, Life Cycle Leader for Xenical.

    The CPMP's positive opinion will now be proposed for approval by the European Commission.

    Type 2 diabetes

    Health experts have warned of a global epidemic of diabetes caused by a
    '"/>



  • Contact: Liz Gofton
    liz.gofton@shirehealthinternational.com
    44-207-471-1518
    Shire Health International
    30-Jan-2004


    Page: 1 2

    Related medicine news :

    1. Reduced progression of atherosclerosis tied to statin drugs lowering fats, protein
    2. Reduced risk of institutionalisation in patients with dementia
    3. Reduced exposure tobacco products lessen carcinogen exposure, but medicinal nicotine better
    4. Reduced scarring helps nerves grow through spinal injuries
    5. Reduced breastfeeding in western countries makes major contribution to incidence of breast cancer
    6. WIC, Medicaid Have Reduced Infant Deaths
    7. Cervical Screening Has Reduced Incidence And Mortality From Cervical Cancer
    8. Reduced Heart Disease Risk In Middle Age Lowers Eventual Medicare Costs
    9. Study Leads To New Standard Of Care For Treating Unstable Angina: Heart-Attack Risk Reduced By 47% With Use Of Tirofiban
    10. Hospital acquired infections present major problem for infants in developing countries
    11. Helping answer needs by developing specialists in autism

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
    (Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
    (Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
    (Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
    Breaking Medicine News(10 mins):
    (Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
    (Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
    (Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
    Breaking Medicine Technology:
    Cached News: